About this trial
The objective of this prospective observational study is to rigorously examine the feasibility and efficacy of utilizing latent diffusion models for data augmentation in anti-nuclear antibody (ANA) Hep-2 cell immunofluorescence images. The main question it aims to answer is:
Can the application of such models potentially enhance the data quality, increase sample diversity, or improve the accuracy and efficiency of subsequent analytical processes (like disease diagnosis and classification) when utilized with ANA-related images?
Eligibility criteria
Qualifiers
Originating from reputable medical institutions
Possessing relevant certification and qualifications
Having over one year of experience in interpreting anti-nuclear antibody (ANA) patterns within a laboratory setting
Disqualifiers
Lacking relevant professional certification and qualifications
Without experience in interpreting ANA patterns
Unwilling to accept the rules and informed consent of the visual Turing test
Trial design
Treatments tested in this trial
- referring to the results of AI model output